We are live on
!
Find out more
BM
Bridger Management Portfolio holdings
AUM
$128M
1-Year Est. Return
9.54%
This Fund
S&P 500
This Quarter
Est. Return
+18.86%
1 Year Est. Return
+9.54%
3 Year Est. Return
+98.31%
5 Year Est. Return
+125.76%
10 Year Est. Return
+911.97%
AUM
$301M
AUM Growth
+$32.5M
(+12%)
Cap. Flow
+$15.1M
Cap. Flow
% of AUM
5.02%
Top 10 Holdings %
Top 10 Hldgs %
64.21%
Holding
40
New
11
Increased
2
Reduced
6
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$14.3M |
| 2 |
Bath & Body Works
BBWI
|
+$13.6M |
| 3 |
Eli Lilly
LLY
|
+$11.8M |
| 4 |
CTLT
CATALENT, INC.
CTLT
|
+$10.6M |
| 5 |
US Foods
USFD
|
+$9.78M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$13.6M |
| 2 |
PSPC.U
Post Holdings Partnering Corporation Units, each consisting of one share of Series A common stock, and one-third of one redeemable warrant
PSPC.U
|
+$12.7M |
| 3 |
VeriSign
VRSN
|
+$10M |
| 4 |
MDU Resources
MDU
|
+$8.31M |
| 5 |
BellRing Brands
BRBR
|
+$6.36M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 38.62% |
| 2 | Consumer Discretionary | 22.03% |
| 3 | Technology | 20.32% |
| 4 | Communication Services | 6.76% |
| 5 | Financials | 6.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Uber
UBER
$142B
| $34.3M | 11.38% |
794,557
-61,100
| -7% | -$2.27M |
|
2
Melco Resorts & Entertainment
MLCO
$2.25B
| $24M | 7.96% |
1,965,122
+261,300
| +15% | +$3.23M |
|
3
Caesars Entertainment
CZR
$6.05B
| $23.7M | 7.85% |
464,525
| – | – |
|
4
GoDaddy
GDDY
$10.5B
| $20.3M | 6.72% |
269,803
-23,150
| -8% | -$1.71M |
|
5
Charter Communications
CHTR
$17.3B
| $18.7M | 6.2% |
50,913
| – | – |
|
6
Morgan Stanley
MS
$334B
| $15.5M | 5.15% |
181,914
-62,400
| -26% | -$5.34M |
|
7
Alcon
ALC
$33.4B
| $14.9M | 4.96% |
181,977
+19,550
| +12% | +$1.49M |
|
|
8
Vertex Pharmaceuticals
VRTX
$120B
| $14.9M | 4.95% |
+42,400
| New | +$14.3M |
|
|
9
Bath & Body Works
BBWI
$4.02B
| $14M | 4.63% |
+372,100
| New | +$13.6M |
|
10
Biogen
BIIB
$30.2B
| $13.3M | 4.41% |
46,633
-9,644
| -17% | -$2.87M |
|
|
11
Eli Lilly
LLY
$1.02T
| $13.2M | 4.37% |
+28,076
| New | +$11.8M |
|
12
BioMarin Pharmaceuticals
BMRN
$11.5B
| $12.4M | 4.11% |
142,979
| – | – |
|
13
Teva Pharmaceuticals
TEVA
$40.6B
| $11.3M | 3.75% |
1,500,000
| – | – |
|
|
14
US Foods
USFD
$22B
| $10.8M | 3.6% |
+246,431
| New | +$9.78M |
|
|
CTLT
15
DELISTED
CATALENT, INC.
CTLT
| $10.5M | 3.47% |
+241,338
| New | +$10.6M |
|
|
IMGN
16
DELISTED
Immunogen Inc
IMGN
| $8.82M | 2.92% |
+467,220
| New | +$5.52M |
|
|
DCBO
17
Docebo
DCBO
$515M
| $5.49M | 1.82% |
138,592
-16,615
| -11% | -$602K |
|
18
Bausch + Lomb
BLCO
$5.9B
| $4.93M | 1.63% |
+245,431
| New | +$4.45M |
|
19
Sotera Health
SHC
$5.04B
| $4.91M | 1.63% |
+260,400
| New | +$4.14M |
|
20
Crown Holdings
CCK
$12.7B
| $4.79M | 1.59% |
+55,100
| New | +$4.54M |
|
21
Sable Offshore Corp
SOC
$953M
| $4.55M | 1.51% |
443,000
-57,000
| -11% | -$580K |
|
22
Quanterix
QTRX
$160M
| $3.49M | 1.16% |
154,900
| – | – |
|
|
WRAC
23
DELISTED
Williams Rowland Acquisition Corp.
WRAC
| $3.08M | 1.02% |
297,000
| – | – |
|
24
Knife River
KNF
$4.17B
| $2.97M | 0.98% |
+68,199
| New | +$2.89M |
|
|
RETA
25
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $2.53M | 0.84% |
24,800
| – | – |
|
Similar funds
SHFC
IUC
PC
SIM
PIA
S
CF
BC
Bridger Management's Q2 2023 Portfolio in Review
As of Q2 2023, Bridger Management held 40 positions worth $301M, up 12% from $269M the previous quarter. Its ten largest holdings account for 64% of the portfolio.
Bridger Management deployed $15.1M of net new capital in Q2 2023, opening 11 new positions and adding to 2 existing holdings. Its largest new stake was Vertex Pharmaceuticals: 42,400 shares worth $14.9M.
By sector, the portfolio is most concentrated in Healthcare at 39% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Morgan Stanley, an estimated $5.34M trimmed.
- Bridger Management's largest Q2 2023 buy was Vertex Pharmaceuticals: 42,400 shares worth $14.9M.
- Bridger Management added most to Melco Resorts & Entertainment in Q2 2023, an estimated $3.23M increase.
- Bridger Management's biggest Q2 2023 reduction was Morgan Stanley, cutting an estimated $5.34M.
- Bridger Management fully exited Activision Blizzard in Q2 2023, selling an estimated $13.6M.
- Bridger Management's ten largest holdings make up 64% of its $301M portfolio in Q2 2023.
- Bridger Management opened 11 new positions and closed 10 in Q2 2023.
- Bridger Management's portfolio value rose 12% quarter-over-quarter to $301M.
Based on Bridger Management's 13F filing for Q2 2023, filed 14 Aug 2023.